Key Finding
Electroacupuncture at ST36 provided superior pain relief and anxiety reduction compared to GV20 and HT7 in chronic pain-anxiety comorbidity, with anxiolytic effects dependent on opioid-mediated analgesia as demonstrated by naloxone reversal.
Researchers studied whether electroacupuncture could help mice experiencing both chronic inflammatory pain and anxiety together—a common real-world scenario where pain and emotional distress occur simultaneously. They tested three different acupuncture points: Zusanli (ST36) on the leg, Baihui (GV20) on the head, and Shenmen (HT7) on the wrist. The study involved 100 mice total across two experiments, with treatments given daily for six days starting 12 days after pain was induced. The results showed that electroacupuncture at ST36 provided the best relief for both pain and anxiety compared to the other points tested. Mice receiving ST36 treatment showed increased pain thresholds and demonstrated less anxious behavior in standard tests—they spent more time exploring open, anxiety-inducing spaces. Brain imaging revealed that ST36 treatment reduced overactivity in several brain regions involved in processing pain and emotion, including the anterior cingulate cortex and thalamus. When researchers gave mice naloxone (a drug that blocks the body's natural pain-relief system), the benefits of ST36 treatment disappeared, suggesting the anxiety relief depends on pain reduction through the body's opioid pathways. This research indicates that for people dealing with both chronic pain and anxiety, acupuncture at ST36 may address both conditions simultaneously by calming overactive pain and emotion centers in the brain. If you're considering acupuncture for pain-related anxiety, seek treatment from a licensed acupuncturist trained in traditional point selection and electroacupuncture techniques.
This controlled study (n=100 C57BL/6 mice) compared electroacupuncture efficacy at ST36, GV20, and HT7 for chronic inflammatory pain-anxiety comorbidity induced by complete Freund's adjuvant. Treatment consisted of bilateral EA (2/100 Hz, 0.2-0.4 mA) for 30 minutes daily over 6 days beginning day 12 post-induction. ST36 demonstrated superior outcomes compared to GV20 and HT7, significantly improving paw withdrawal thresholds (P<0.01) and anxiety behaviors in elevated plus maze and open field tests (P<0.01-0.05). Immunofluorescence revealed ST36 reduced c-Fos expression in bilateral ACC, contralateral mPFC, bilateral PVT, and bilateral MD (P<0.05). Naloxone pretreatment abolished ST36's analgesic and anxiolytic effects while reversing neuronal suppression in ACC and MD (P<0.05), indicating the emotional benefits depend on opioid-mediated analgesia. Clinical implications suggest ST36 may be preferred for pain-anxiety comorbidity, with anxiolytic effects contingent upon analgesic mechanisms via ACC and MD modulation.
Browse our directory of verified licensed practitioners near you.
Find a practitioner →📌 Manual acupuncture significantly reduced anxiety symptoms post-treatment compared to both sham acupuncture and usual care, with effects sustained at follow-up versus sham acupuncture but not usual care.
📌 This is a systematic review protocol outlining plans to evaluate MSRT's effects on anxiety, sleep quality, and quality of life in adults, but does not yet contain actual findings from completed research.
📌 Acupuncture combined with SSRI/SNRI medications significantly reduced anxiety scores in somatic symptom disorder patients at 4 weeks compared to medication alone, though evidence quality was low and pain outcomes showed no significant benefit.